Background: Pathological internet use is of increasing significance in several industrial nations. Sampling and Methods: We surveyed a representative German quota sample of 1,723 adolescents (aged 14-17 years) and 1 caregiver each. We conducted a latent profile analysis to identify a high-risk group for pathological internet use. Results: Overall, 3.2% of the sample formed a profile group with pathological internet use. In contrast to other published studies, the results of the latent profile analysis were verified not only by self-assessments of the youth's but also by external ratings of the caregivers. In addition to the pathological internet use, the high-risk group showed lower levels of family functioning and life satisfaction as well as more problems in family interactions. Conclusions: The results showed a considerable prevalence of pathological internet use in adolescents and emphasized the need for preventive and therapeutic approaches.

Khazaal Y, Chatton A, Horn A, Achab S, Thorens G, Zullino D, Billieux J: French validation of the compulsive internet use scale (CIUS). Psychiatr Q 2012;83:397-405.
Petry NM, O'Brien CP: Internet gaming disorder and the DSM-5. Addiction 2013;108:1186-1187.
Pies R: Should DSM-V designate ‘internet addiction' a mental disorder? Psychiatry 2009;6:31-37.
Shaw M, Black DW: Internet addiction: definition, assessment, epidemiology and clinical management. CNS Drugs 2008;22:353-365.
Carli V, Durkee T, Wasserman D, Hadlaczky G, Despalins R, Kramarz E et al: The association between pathological internet use and comorbid psychopathology: a systematic review. Psychopathology 2013;46:1-13.
Cao H, Sun Y, Wan Y, Hao J, Tao F: Problematic internet use in Chinese adolescents and its relation to psychosomatic symptoms and life satisfaction. BMC Public Health 2011;11:802.
Yen JY, Yen CF, Chen CC, Chen SH, Ko CH: Family factors of internet addiction and substance use experience in Taiwanese adolescents. Cyberpsychol Behav 2007;10:323-329.
Park SK, Kim JY, Cho CB: Prevalence of internet addictions and correlations with family factors among South Korean adolescents. Adolescence 2008;43:895-909.
Young K: Caught in the Net. New York, Wiley, 1998.
Chen SH, Weng LC, Su YJ, Wu HM, Yang PF: Development of the Chinese Internet Addiction Scale and its psychometric study. Chinese J Psychol 2003;45:279-294.
Meerkerk GJ, Van Den Eijnden RJJM, Vermulst AA, Garretsen, HFL: The Compulsive Internet Use Scale (CIUS): some psychometric properties. Cyberpsychol Behav 2009;12:1-6.
Rumpf HJ, Vermulst AA, Bischof A, Kastirke N, Gürtler D, Bischof G, et al: Occurrence of internet addiction in a general population sample: a latent class analysis. Eur Addict Res 2014;20:159-166.
Durkee T, Kaess M, Carli V, Parzer P, Wasserman C, Floderus B et al: Prevalence of pathological internet use among adolescents in Europe: demographic and social factors. Addiction 2012;107:2210-2222.
Young K: Internet addiction: the emergence of a new clinical disorder. Cyberpsychol Behav 1998;1:237-244.
Grant JE, Schreiber LR, Odlaug BL: Phenomenology and treatment of behavioural addictions. Can J Psychiatry 2013;58:252-259.
Bundeszentrale für gesundheitliche Aufklärung (BZgA): Die Drogenaffinität Jugendlicher in der Bundesrepublik Deutschland 2011. Der Konsum von Alkohol, Tabak und illegalen Drogen: aktuelle Verbreitung und Trends. Köln, BZgA, 2012.
Kraus L, Pabst A, Piontek D: Europäische Schülerstudie zu Alkohol und anderen Drogen 2011 (ESPAD): Befragung von Schülerinnen und Schülern der 9. und 10. Klasse in Bayern, Berlin, Brandenburg, Mecklenburg-Vorpommern und Thüringen. München, Institut für Therapieforschung, 2012.
American Psychological Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Publishing, 1994.
Griffiths M: Internet addiction: fact or fiction? Psychologist 1999;12:246-250.
Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, et al: An international consensus for assessing internet gaming disorder using the new DSM-5 approach. Addiction 2014;109:1399-1406.
Cierpka M, Frevert G: Die Familienbögen - Ein Inventar zur Einschätzung von Familienfunktionen. Göttingen, Hogrefe, 1994.
Muthén LK, Muthén BO: Mplus User's Guide, ed 5. Los Angeles, Muthén & Muthén, 1998-2007.
Jung T, Wickrama KAS: An introduction to latent class growth analysis and growth mixture modeling. Soc Personal Psychol Compass 2008;2:302-317.
Nylund KL, Asparouhov T, Muthen BO: Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Modeling 2007;14:535-569.
Lo Y, Mendell NR, Rubin DB: Testing the number of components in a normal mixture. Biometrika 2001;88:767-778.
Bender R, Lange S: Adjusting for multiple testing - when and how? J Clin Epidemiol 2001;54:343-349.
Meerkerk GJ, van den Eijnden RJJM, Franken IHA, Garretsen HFL: Is compulsive internet use related to sensitivity to reward and punishment, and impulsivity? Comput Human Behav 2010;26:729-735.
Bischof G, Bischof A, Meyer C, John U, Rumpf HJ: Prävalenz der Internetabhängigkeit - Diagnostik und Risikoprofile (PINTA-DIARI). Kompaktbericht an das Bundesministerium für Gesundheit. Lübeck, Klinik für Psychiatrie und Psychotherapie der Universität Lübeck, 2013.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.